Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Cody J. Lensing"'
Autor:
Callahan N. Clark, Elizabeth L. Eby, Cody J. Lensing, Elena Fultz, Brian Hart, Lilian Lingcaro, Ron Hoffner, Nanette C. Schloot, Brian D. Benneyworth
Publikováno v:
Diabetes Therapy. 14:869-882
Autor:
Cody J. Lensing, Kristina S. Boye, Elif Tokar Erdemir, Robert J. Heine, Scott Sailer, Ramira San Juan, Abraham Reddy, Brian D. Benneyworth, Nathan D. Zimmerman, Emily R. Hankosky, Lida Etemad, Matan C. Dabora, Callahan Clark, M. Angelyn Bethel
Publikováno v:
Diabetes Therapy
Introduction Diabetes has been identified as a high-risk comorbidity for COVID-19 hospitalization. We evaluated additional risk factors for COVID-19 hospitalization and in-hospital mortality in a nationwide US database. Methods This retrospective stu
Autor:
Walter J. Pories, Suchit Mehrotra, Jejomar Derecho, Rossjyn Fallorina, Maria S. Altieri, Eric J. DeMaria, Cody J. Lensing, William Irish
Publikováno v:
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 18(2)
Bariatric surgery has shown an improvement in obesity and obesity-related disease in many clinical trials and single center studies. However, real-world data, including data from non-centers of excellence, is sparse.To provide clinical outcomes of pa
Autor:
Kimberly Luu, Kelly Barger, Athena Philis-Tsimikas, Laura Talavera, Addie L. Fortmann, Alessandra Bastian, Cody J. Lensing, Shane Hoversten
Publikováno v:
Diabetes. 69
Continuous glucose monitors (CGM) are an integral aspect in the glucose management of many individuals with type 1 diabetes, and a growing number of people with insulin-requiring type 2 diabetes (T2D). A 2019 meta-analysis of 7 randomized controlled
Autor:
Jared P. Jones, Ben W. Ehlert, Jessyca M. Duerr, Stephen R. Garth, Craig D. Wagner, Cody J. Lensing, Shane Hoversten, Kevin A. Kapov
Publikováno v:
Diabetes Spectr
IN BRIEF In this article, the authors discuss several innovative concepts UnitedHealth Group Research & Development is exploring to help patients manage their type 2 diabetes. The article focuses on efforts to use remote support programs and wearable
Autor:
Aleksandar Todorovic, Carrie Haskell-Luevano, Cody J. Lensing, Joseph W. Scott, Jerry Ryan Holder, Nicholas B. Sorensen
Publikováno v:
ACS Chemical Neuroscience. 9:2753-2766
The melanocortin system regulates an array of diverse physiological functions including pigmentation, feeding behavior, energy homeostasis, cardiovascular regulation, sexual function, and steroidogenesis. Endogenous melanocortin agonist ligands all p
Autor:
Katie T. Freeman, Jay W. Schaub, Stacey L. Wilber, Carrie Haskell-Luevano, Cody J. Lensing, Marvin L. Dirain, Srinivasa R. Tala, Viktor Flores, Mark D. Ericson, Erica M. Haslach, Branden A. Smeester, Robert C. Speth, Natalie Eick, Anamika Singh, Danielle N. Adank
Publikováno v:
Journal of Medicinal Chemistry. 61:3738-3744
β-Defensin 3 (BD3) was identified as a ligand for the melanocortin receptors (MCRs) in 2007, although the pharmacology activity of BD3 has not been clearly elucidated. Herein, it is demonstrated that human BD3 and mouse BD3 are full micromolar agoni
Autor:
James R. Rocca, Katie T. Freeman, Sathya M. Schnell, Carrie Haskell-Luevano, Srinivasa R. Tala, Anamika Singh, Cody J. Lensing
Publikováno v:
ACS Chemical Neuroscience. 9:1001-1013
The melanocortin system is involved in the regulation of complex physiological functions, including energy and weight homeostasis, feeding behavior, inflammation, sexual function, pigmentation, and exocrine gland function. The five melanocortin recep
Autor:
Mark D. Ericson, Katherine N. Schlasner, Cody J. Lensing, Skye R. Doering, Carrie Haskell-Luevano, Katlyn A. Fleming
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863:2414-2435
The discovery of the endogenous melanocortin agonists in the 1950s have resulted in sixty years of melanocortin ligand research. Early efforts involved truncations or select modifications of the naturally occurring agonists leading to the development
Autor:
Danielle N. Adank, Katie T. Freeman, Sathya M. Schnell, Carrie Haskell-Luevano, Cody J. Lensing, Stacey L. Wilber, Adam T. Zarth, Robert C. Speth
Publikováno v:
ACS Chemical Neuroscience. 8:1262-1278
Bivalent ligands targeting putative melanocortin receptor dimers have been developed and characterized in vitro; however, studies of their functional in vivo effects have been limited. The current report compares the effects of homobivalent ligand CJ